Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Prodrug modulators of the integrated stress pathway 2024-1-02 2024-1-25
Protein tyrosine phosphatase inhibitors and methods of use thereof 2023-11-10 2023-11-30
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[ … 2023-10-19 2023-11-09
Cocrystals of upadacitinib 2023-10-06 2024-2-08
PRODRUGS OF CARBIDOPA AND L-DOPA AND THEIR USE TO TREAT PARKINSON’S DISEASE 2023-9-29 2023-12-08
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 … 2023-9-07 2024-1-04
Modulators of the integrated stress pathway 2023-9-07 2024-1-18
Modulators of the integrated stress pathway 2023-9-07 2024-1-04
Methods of Administering Elagolix 2023-9-06 2023-12-28
Anti-EGFR antibody drug conjugate 2023-8-10 2023-11-21
ANTI-GARP-TGF-β1/PD-1 COMBINATION THERAPY 2023-7-28 2024-2-01
ANTI-CD71 ACTIVABLE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE OF THESE 2023-7-27 2023-8-31
Methods of treating systemic lupus erythematosus 2023-7-27 2024-2-01
Anti-cmet antibody drug conjugates and methods their use 2023-7-25 2023-9-01
Pharmaceutical formulations for treating endometriosis, uterine fibroids, … 2023-7-12 2023-10-18
Systems and methods for identifying protein aggregates in biotherapeutics 2023-7-03 2024-1-11
Anti-cd19 antibody drug conjugates 2023-6-15 2023-12-21
Risankizumab compositions 2023-6-15 2023-12-21
Carbidopa and l-dopa prodrugs and methods of use 2023-6-14 2024-1-25
Anti-EGFR antibodies and antibody drug conjugates 2023-6-08 2023-7-06
Levodopa and carbidopa intestinal gel and methods of use 2023-5-29 2023-6-22
Methods of treating heavy menstrual bleeding 2023-5-15 2023-9-14
Methods of Treating Heavy Menstrual Bleeding 2023-5-15 2023-9-07
Methods of Administering Elagolix 2023-5-05 2023-8-31
Modulators of the integrated stress pathway 2023-4-28 2023-5-18
Devices and methods for delivering a beneficial agent to a user 2023-4-28 2023-9-14
Modulators of the integrated stress pathway 2023-4-27 2023-12-01
Salts and pharmaceutical compositions thereof for the treatment of inflammatory … 2023-4-25 2023-12-21
Monoclonal antibodies against rgm a protein and uses thereof 2023-4-17 2023-7-26
Crystal forms 2023-4-12 2023-6-27
Thiazolo[5,4-b]pyridine malt-1 inhibitors 2023-3-30 2023-10-05
Method of administering upadacitinib to avoid adverse drug interactions and … 2023-3-28 2023-7-27
Modulators of the integrated stress pathway 2023-3-23 2023-4-27
Methods for treating relapsing forms of multiple sclerosis 2023-3-10 2023-5-30
Methods of treatment of non-small-cell lung carcinoma using telisotuzumab … 2023-3-10 2023-9-14
Modulators of the integrated stress pathway 2023-3-07 2023-4-06
CARBINDOPA AND L-DOPA PRODRUGS AND THEIR USE IN THE TREATMENT OF PARKINSON'S … 2023-3-07 2023-6-09
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2023-3-01 2023-6-29
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2023-3-01 2023-10-05
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2023-3-01 2023-7-20
Composition and method for diagnosing and treating iron-related disorders 2023-2-28 2023-6-06
Levodopa and carbidopa intestinal gel and methods of use 2023-2-16 2023-4-25
Methods of treatment of diseases in which il-13 activity is detrimental using … 2023-2-03 2023-7-13
Anti-αlfa-4-βeta-7 antibodies 2023-1-31 2023-2-06
Anti-EGFR antibody drug conjugate formulations 2023-1-27 2023-3-02
1,3,4,7-Tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 … 2023-1-19 2023-7-27
Protein tyrosine phosphatase inhibitors and methods of use thereof 2022-12-27 2023-4-11
Dosing regimens for use in treating relapsed and refractory multiple myeloma … 2022-12-08 2023-6-15
Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof 2022-12-01 2023-3-14
Protein tyrosine phosphatase inhibitors and methods of use thereof 2022-11-10 2023-5-19
Treatment of major depressive disorder 2022-10-28 2023-5-18
Anti-amyloid beta antibodies and methods of using the same 2022-10-28 2023-5-04
Subcutaneously administered treatments for advanced parkinson's disease 2022-10-27 2023-6-01
Salts and crystalline forms of an apoptosis-inducing agent 2022-10-18 2023-10-05
Macrocyclic mcl-1 inhibitors and methods of use 2022-10-12 2023-12-14
Treating spondyloarthritic and psoriatic conditions with upadacitinib 2022-10-12 2023-11-16
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune … 2022-10-07 2024-2-13 2024-2-13
Treating spondyloarthritic conditions with upadacitinib 2022-10-05 2023-4-13
Topical formulation 2022-9-28 2022-10-27
Anti-Viral Compounds 2022-9-09 2023-9-14
Solid pharmaceutical compositions for treating hcv 2022-8-26 2022-11-30
Process of making apoptosis-inducing agents 2022-8-25 2023-3-02
Protein tyrosine phosphatase targeting ligands 2022-8-10 2023-2-16
Nicotinamide ripk1 inhibitors 2022-8-08 2023-6-01
Methods for treating HCV 2022-7-29 2022-8-25
Anti-CCR8 antibodies 2022-7-27 2023-5-02 2023-5-02
Crystal forms 2022-7-07 2022-9-13
Bromodomain inhibitors 2022-6-30 2023-5-25
Degrader compounds and uses thereof 2022-6-21 2024-2-01
Protein tyrosine phosphatase inhibitors and methods of use thereof 2022-6-16 2023-1-19
Modulators of the integrated stress pathway 2022-6-14 2023-5-11
Anti-CD40 antibodies and uses thereof 2022-6-10 2022-6-30
Anti-cd98 antibodies and antibody drug conjugates 2022-6-08 2023-5-04
Methods of treating acute myeloid leukemia and managing cytopenia 2022-6-07 2023-1-05
Devices and methods for delivering a beneficial agent to a user 2022-5-20 2022-12-01
Isolation and purification of anti-il-13 antibodies using protein a affinity … 2022-5-17 2022-10-27
Venetoclax dosing regimens for use in treating myelodysplastic syndromes in … 2022-5-10 2022-11-17
Venetoclax dosing regimens for use in treating myelodysplastic syndromes in … 2022-5-10 2024-1-01
Medication packaging and dispensing system 2022-5-10 2022-8-25
Dosing regimens for use in the treatment of myelofibrosis and mpn-related … 2022-5-04 2023-1-20
IL-1 Binding Proteins 2022-4-29 2023-4-13
Anti-c-met antibody drug conjugates 2022-4-29 2022-12-01
Methods of treating crohn's disease and ulcerative colitis 2022-4-28 2023-1-31 2023-1-31
Anti-cd98 antibodies and antibody drug conjugates 2022-4-27 2023-4-20
Subcutaneously administered treatments for advanced parkinson's disease 2022-4-25 2023-4-27
Macrocyclic mcl-1 inhibitors and methods of use 2022-4-22 2022-8-18
Elagolix Sodium Compositions and Processes 2022-4-14 2022-10-13
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[ … 2022-4-11 2022-8-11
Methods of treatment of non-small-cell lung carcinoma using telisotuzumab … 2022-4-06 2022-10-13
Methods of treating crohn's disease and ulcerative colitis 2022-4-01 2022-7-28
Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses … 2022-3-23 2023-6-15
Enzyme compositions with reduced viral and microbial contamination 2022-3-21 2022-7-07
Bromodomain Inhibitors 2022-3-11 2023-3-30
Anti-egfr antibody drug conjugates 2022-3-08 2023-4-13
Monoclonal antibodies against amyloid beta protein and uses thereof 2022-3-08 2022-6-21
System and method of multi-drug delivery 2022-2-27 2022-4-01
Monoclonal antibodies against amyloid beta protein and uses thereof 2022-2-24 2022-3-17
Anti-cd40 antibodies and their uses 2022-2-18 2022-5-09
Modulators of the integrated stress pathway 2022-2-11 2022-3-03
Macrocyclic MCL-1 Inhibitors and Methods of Use 2022-2-03 2023-6-15